Patients in pCR and non-pCR groups exhibited no significant differences in baseline clinicopathological features including age at diagnosis, menopausal status, tumor laterality, T and N stage, ER and PR status, and the expression level of Ki67. This evidence concerns the gene ESR1 and neoplasm.